OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
33
Results
Show all
Save search
Copy query
Show results for
Unknown
(33)
Publication Date
Release Date
2023
(8)
2025
(6)
2021
(5)
2024
(4)
2019
(3)
2022
(2)
2020
(2)
2026
(1)
2014
(1)
2012
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait.
Not available
S-EPMC10268479
|
biostudies-literature
Cite
Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases.
Not available
S-EPMC9674405
|
biostudies-literature
Cite
Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.
Not available
S-EPMC7452956
|
biostudies-literature
Cite
Experimental supporting data on DIS3L2 over nonsense-mediated mRNA decay targets in human cells.
Not available
S-EPMC6921154
|
biostudies-literature
Cite
A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer.
Not available
S-EPMC12020112
|
biostudies-literature
Cite
Anti-Inflammatory Effects of 5α,8α-Epidioxycholest-6-en-3β-ol, a Steroidal Endoperoxide Isolated from
Aplysia depilans
, Based on Bioguided Fractionation and NMR Analysis.
Not available
S-EPMC6628248
|
biostudies-literature
Cite
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma.
Not available
S-EPMC6721528
|
biostudies-literature
Cite
BBIT20 inhibits homologous DNA repair with disruption of the BRCA1-BARD1 interaction in breast and ovarian cancer.
Not available
S-EPMC9124438
|
biostudies-literature
Cite
Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting.
Not available
S-EPMC4289236
|
biostudies-literature
Cite
Cross-sectional study on protective antibodies against influenza A virus subtypes and cross-protection against influenza A(H3N2) subclade K, Portugal, August 2025.
Not available
S-EPMC12905529
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets